News
CPhI Worldwide announces the finalists for the CPhI Pharma Awards. The shortlist spans 13 different categories across the full spectrum...
Read more
News that has taken the Pharmaceutical sector by storm, Amgen has announced positive results for 2 phase 3 BLINCYTO® (blinatumomab)...
Read more
Regeneron Pharmaceuticals, Inc. and Sanofi announced that the European Medicines Agency'sCommittee for Medicinal Products for Human Use (CHMP) has adopted...
Read more
Constellation Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, announced that...
Read more
Incyte announced that the first patient has been treated in the Phase 3 TRuE-V clinical trial program evaluating the safety...
Read more
Zogenix, Inc, a global pharmaceutical company developing rare disease therapies, announced that it has entered into a definitive agreement to...
Read more
ADC Therapeutics, an oncology drug discovery and development company that specializes in the development of antibody drug conjugates (ADCs), and...
Read more
 DiscGenics, Inc., a clinical stage biotechnology company focused on developing regenerative cell-based therapies that alleviate pain and restore function in...
Read more
Bayer AG and BlueRock Therapeutics announced an agreement under which Bayer will fully acquire BlueRock Therapeutics, a privately held US-headquartered...
Read more
LexaGene Holdings, Inc. , a biotechnology company that develops genetic analyzers for rapid pathogen detection and other molecular markers, announced ...
Read moreLatest News
About Us
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
